Bioconjugates play an important role in several fields of biomolecular and biomedicinal sciences. Protein/polypeptide-based conjugates with covalently attached epitope peptides are considered as potential synthetic vaccine candidates and/or target antigens in affinity-based bioassays. This chapter describes the synthesis of two-and three-component bioconjugates using water-soluble branched chain polymeric polypeptides with multiple amino and/or carboxyl groups as macromolecular partners and oligopeptides as epitopes with small molecular mass. The synthetic procedures outline three major strategies for the incorporation of multiple copies of uniformly oriented peptide epitopes. In the first example, chloroacetylated polypeptide is conjugated with SH-peptide to form a thioether linkage. Second, two independent oligopeptides are introduced into a macromolecule by amide and disulfide bonds, respectively. In the third example, a new procedure is reported for the formation of disulfide bridges by the use of Npys-modified polypeptide and SHpeptide.
Introduction
Bioconjugates play an important role in several fields of biomolecular and biomedicinal sciences. Protein/polypeptide-based conjugates with covalently attached epitope peptides are considered as potential synthetic vaccine candidates and/or target antigens in affinity-based bioassays (e.g., ELISA, BIACORE) (1, 2) . Drugs such as daunomycin, methotrexate, and a GnRH analog coupled either to monoclonal antibodies or to synthetic linear or branched polypeptides exhibit altered biodistribution and decreased nonspecific toxicity (e.g., cardiotoxicity). Consequently, the therapeutic effects of such drugs can be markedly improved by conjugation (3) (4) (5) . Bioconjugates could be classified either by the number and size of components involved or by the type of covalent linkage applied between the partner entities. This chapter describes the synthesis of two-and three-component bioconjugates combining water-soluble branchedchain polymeric polypeptides as the macromolecular partners of small molecular mass bioactive oligopeptides. Collectively, the bioconjugates presented possess not only the most frequently utilized amide and/or disulfide linkage, but also the thioether bond. The synthetic procedures outlined could also be adapted to the preparation of conjugates containing macromolecular partners with similar functional groups (e.g., proteins and synthetic polymers).
Branched polypeptides developed in our laboratory with the general formula poly[Lys(X i -DL-Ala m )] (XAK), where i < 1, m approx 3, and X represents the side-chain terminal residue (6-8) will be used ( Fig. 1) to illustrate the methods utilized for different conjugation procedures. Depending on the nature of the amino acid X, polypeptides exhibit polycationic (e.g., poly[Lys(DL-Ala m )], poly[Lys(Ser i -DL-Ala m )], amphoteric (e.g., poly[Lys(Glu i -DL-Ala m ), or polyanionic (e.g., poly[Lys(Ac-Glu i -DL-Ala m )]) character under physiological conditions (pH 7.3 in 0.15 M NaCl). These macromolecules were applied for the synthesis of B-cell epitope peptide conjugates to be used as target antigens for the specific and sensitive detection of mucin 1 glycoprotein-specific antibodies (9), of T-cell epitope conjugates with peptides derived from 16/38-kDa proteins from M. tuberculosis (10-13) and of peptides containing HSV-neutralizing antibody epitope(s) (14, 15) . In these conjugates the oligopeptide component(s) was/were coupled in multiple copies in a uniformly oriented manner. By these constructs we have shown that (1) peptides attached to carriers preserved their biological function (e.g., antibody binding, T-cell recognition, specific immunogenicity, interaction with phospholipid mono-or bilayers), and (2) the physicochemical properties of the polypeptide component have a marked influence on the attached epitope-related activities (1,13,16).
Materials
1. Amino acid derivatives, reagents for coupling and analysis, organic solvents, buffers, and HPLC eluents used for the preparation of oligo-and polypeptides are identical with those described in Chapter 4. 2. Branched-chain polypeptides poly[Lys-(X i -DL-Ala m )], where X = Glu, Ser, or BocCys(Npys)Opfp, were produced in our laboratory as described. 3. Cross-linking compound ]3-(2-pyridyldithio) propionic acid N-hydroxy-succinimide ester (SPDP) (Sigma, Poole, UK). 4. Benzotriazol-1-yl-oxytris(dimethylamino)phosphonium hexafluorophosphate (BOP) (Fluka, Buchs, Switzerland). 5. Chloroacetic acid pentachlorophenyl ester (ClAc-Opcp) (Fluka). 6. DL-dithiothreitol (DTT) (Fluka).
Methods
Abbreviations used in this chapter follow the rules of the IUPAC-IUB Commission of Biochemical Nomenclature (17) in accordance with the recommended nomenclature of graft polymers (18).
Synthesis of Branched-Chain Polymer Polypeptides
The synthesis of branched polypeptides used for the preparation of all conjugates described in this account was published in detail earlier (6) (7) (8) . Briefly, poly [Lys] was prepared by the polymerization of N a -carboxy-N e -benzyloxycarbonyl-lysine anhydride. After cleavage of the protecting groups, poly[Lys (DL-Ala m )] (AK) was produced by grafting of short oligomeric DL-Ala side chains onto the e-amino groups of poly [Lys] . Benzyloxycarbonyl-protected amino acid derivatives (Z-Ser-OPcp and Z-Glu(OBzl)-OPcp) were coupled to the end of the side chains of AK by the HOBt-catalyzed active ester method. Blocking groups were removed completely with HBr in glacial acetic acid, as confirmed by UV spectroscopy at 254 nm, resulting in poly[Lys(X i -DL-Ala m )] (XAK) polymers (where i £ 1 and m » 3, X = Ser or Glu). The amino acid composition of polypeptides as well as peptide conjugates were determined by amino acid analysis using a Beckman (Fullerton, CA) model 6300 amino acid analyzer. Prior to the analysis, samples were hydrolyzed in 6 M HCl in sealed and evacuated tubes at 110°C for 24 h. The size and molecular weight of polymers were calculated from the amino acid composition and the sedimentation analysis of poly[Lys] (19).
Synthesis and Characterization of Epitope Peptides
Peptides used in these studies for conjugate synthesis were prepared by Boc/ Bzl strategy on MBHA resin or by Fmoc-based chemistry on Rink-amide resin as described in Chapter 4. For incorporation of SH group at the N-terminal (C 91 SEFAYGSFVRTVSLPVGADE 110 ) or C-terminal position (H- 9 LKNleADPNR FRGKDL 22 C-NH 2 , [Nle 11 ]-9-22-Cys) or in a central position (H-LKNleADPN RFRGKDL-Acp-CSALLEDPVG-NH 2 ), a Cys derivative, Boc-Cys(Meb)-OH, was added to the native sequence. After the removal of the peptides from the resin the crude products were purified by RP-HPLC and the purified samples were characterized by analytical HPLC, amino acid analysis and mass spectrometry as detailed in Chapter 4.
Two-Component Conjugate Containing Multiple Copies of Uniformly Oriented Antibody Peptide Epitope
Synthetic oligopeptides comprising linear or continuous topographic B-cell epitope sequences might be considered as specific and small-size antigens. It has been demonstrated that the avidity and specificity of antibody binding could be altered by conjugation to macromolecules or by modification in the flanking regions. However, no systematic studies have been reported to describe the effect of different carrier macromolecules in epitope conjugates. To this end the influence of carrier structure and topology on the antibody recognition of covalently attached herpes simplex virus type 1 glycoprotein D (HSV-1 gD)-related epitopes have been studied by comparing the monoclonal antibody binding properties of a new set of conjugates (20) with branched-chain polypeptide, poly[Lys(Ser i -DL-Ala m )] (SAK), tetratuftsin analog (H-[Thr-Lys-Pro-LysGly] 4 -NH 2 ) sequential oligopeptide carrier (SOC n ), multiple antigenic peptide (MAP), and keyhole limpet hemocyanine (KLH). In these novel constructs peptide 9 LKNleADPNRFRGKDL 22 ([Nle 11 ]-9-22) representing an immunodominant B-cell epitope (21, 22 ) was conjugated to polypeptides through thioether bonds (Fig. 2) .
First, we prepared a derivative of polypeptide SAK possessing chloroacetyl groups in multiple copies at the a-amino groups of the branches. This compound was conjugated with epitope peptides possessing Cys at C-terminal position as outlined in Fig. 3 . Binding data suggest that the chemical nature of the carrier and the degree of substitution have marked influence on the avidity of antibody binding.
Synthesis of Chloroacetylated-Branched Polypeptide poly[Lys(ClAc
80 mg (0.145 mmol) poly[Lys(Ser 0.9 -DL-Ala 3.5 )] HBr salt (SAK, DP n = 60, MW monomer = 550) was dissolved in 1 mL deionized water and the solution was diluted with 4 mL DMF. Chloroacetyl groups were introduced at the N a -amino group of Ser residues by chloroacetic acid pentachlorophenyl ester. Six different SAKs-ClAc-OPcp ratio (1:1, 1:0.8, 1:0.6, 1:0.5, 1:0.4 and 1:0.3 mol/mol; 50 mg, 40 mg, 30 mg, 25 mg, 20 mg, 15 mg ClAc-OPcp respectively) were used and the active ester was added to the polymer containing solution dissolved in 5 mL DMF. The reaction mixtures were stirred overnight at room temperature. The solution was filled in Visking tubes (cutoff 8000-12,000) and dialyzed for 2 d against 0.1% acetic acid and freeze-dried. According to Cl analyses, 46.5%, 45.9%, 48.5%, 41.3%, 30.1%, and 21.7% of the side chains were blocked by the ClAc group, respectively. 21.7 (acetate salt form) were dissolved in 100 mL 0.1 M Tris-HCl buffer (pH 8.2). 1.2 eq (calculated for the chloroacetyl content of the polymers) of epitope peptide (23.4 mg, 20 mg, 14.8 mg, and 10.6 mg respectively) were added in two portions to the solution. The conjugation reaction continued for 24 h and was terminated by addition of an excess of Cys to block the unreacted chloroacetyl groups. Crude products were dialyzed against water to remove uncoupled peptide and Cys in Visking tubes (cutoff 8000-12,000) for 2 d. The average degree of substitution was calculated from the amino acid analyses. Depending on the input molar ratio, 44%, 22%, 9%, and 7% of the side chains was substituted by epitope peptide, respectively.
Three-Component Conjugate Containing Multiple Copies of Two Different, But Uniformly Oriented, T-Cell Peptide Epitopes
For the preparation of three-component conjugates containing multiple copies of two independently introduced and uniformly oriented T-cell peptide epitopes, an amphoteric branched chain polypeptide, poly[Lys-(Glu i -DL-Ala m )] (EAK), was used. This polypeptide, with free a-amino and g-carboxyl groups at the end of the side chains, was conjugated with peptides representing two immunodominant regions of the 16-kDa and 38-kDa proteins of Mycobacterium tuberculosis, respectively (10-12). For conjugation, peptide 65 FNLWGPA FHERYPNVTITA 83 (peptide 1) from the 38-kDa protein possessing free a-amino group at the N-terminal was used without modification, while the second epitope peptide originating from the 16-kDa protein was elongated with an N-terminal Cys [C 91 SEFAYGSFVRTVSLPVGADE 110 ] (peptide 2). Consequently, an amide between the g-COOH of EAK and a-NH 2 of peptide 1 and a disulfide bridge between the a-NH 2 of EAK and SH of peptide 2 were introduced (Fig. 4) .
This synthetic strategy is outlined in Fig. 5 . In the first step, the a-aminogroup of Glu in the side chain of EAK was modified by the heterobifunctional reagent SPDP to introduce protected SH groups into the polymer structure of [(SSP)EAK] (23). The extent of 2-pyridyl-disulfide group incorporation was determined spectrophotometrically from the amount of pyridine-2-thione released by reduction with DTT (10). The unmodified, free a-amino groups of Glu in the branches were blocked by acetylation using a mixture of acetic anhydride and imidazole. In the next step, peptide 1 was coupled to (Ac,SSP)EAK. This was achieved by the BOP reagent-based activation method in which the g-carboxyl group of glutamic acid of (Ac,SSP)EAK was linked to the a-amino group of the phenylalanine residue in peptide 1 to provide isopeptide (g,a type amide) bonding. After isolation of the product the presence of the 2-pyridyl-Hudecz disulfide groups was verified. In the last step, a disulfide bridge was introduced by the substitution of the protecting group of SH of the polymer by peptide 2 [C 91 SEFAYGSFVRTVSLPVGADE 110 ]. The completion of the reaction between (Ac,SSP)E(peptide 1)AK and peptide 2 was spectrophotometrically determined.
In vitro T-cell immunogenicity data obtained with this conjugate using T cell hybridomas, lymph node cells from immunized mice, and human PBMC cultures from PPD-positive individuals indicated that both epitopes were efficiently recognized (10).
Synthesis of poly[Lys-(Ac y ,SSP x -Glu i -DL-Ala m )], (Ac,SSP)EAK
100 mg (215 µmol) EAK was dissolved in 7.5 mL 0.1 M PBS (pH 8.0, adjusted with 1 M NaOH). 20 mg (64.0 µmol) SPDP (Sigma, Poole, UK) was dissolved in 2 mL abs. methanol, and added dropwise to the solution of the polypeptide. The reaction mixture was stirred for 30 min at room temperature and dialyzed for 24 h against distilled water (see Note 1).
110 mg (235 µmol) (SSP)EAK was dissolved in 1 mL distilled water and diluted to 5 mL with DMF at 4°C. In the meantime, 312 µL (3.3 mmol) acetic anhydride and 224 mg (3.3 mmol) imidazole were mixed in 1 mL DMF at 4°C and stirred for 10 min. The two solutions were then mixed, and acetylation was continued for 2 h at room temperature. After dialysis against distilled water, the product was isolated by freeze drying (see Note 2).
Poly[Lys-(Ac y ,SSP x )-Glu i (Peptide 1 )-DL-Ala m )], (Ac,SSP)E(Peptide 1 )AK
10 mg (19 µmol) (Ac,SSP)EAK (calculated on the basis of 19.3% 2-pyridyldisulfide group content, and 80.7% acetyl group content) was dissolved in 1 mL water and diluted five times with DMF. 8.9 mg (20 µmol) BOP reagent, 3.3 mg (25 µmol) HOBt, and 7 µL (40 µmol) DIEA were dissolved in 1 mL DMF. The activating mixture was added to the polymer solution and stirred for 20 min. 10 mg (4.5 µmol) peptide 65 FNLWGPAFHERYPNVTITA 83 (peptide 1), representing 0.25 mol peptide/polymer side chain, was dissolved in 4 mL DMF at a concentration of 2.5 mg/mL DMF, and mixed with 4.5 µmol DIEA. The peptide solution was added to the preactivated polymer solution and allowed to couple for 24 h at room temperature under stirring. The solution was then dialyzed against distilled water for 48 h and the product was isolated by freeze drying.
Poly[Lys-(Ac y ,Peptide 2 )-Glu i (Peptide 1 )-DL-Ala m )], (Ac,Peptide 2 )E(Peptide 1 )AK
10 mg (Ac,SSP)E(Peptide1)AK conjugate (containing 3 µmol protected thiol groups) was dissolved in 1 mL distilled water. 10 mg (4.5 µmol) peptide C-91 SEFAYGSFVRTVSLPVGADE 110 (peptide 2) dissolved in 1 mL PBS (pH 8.0, adjusted with 1 M NaOH) was added to the conjugate solution. The reaction mixture was stirred for 30 min at room temperature, followed by dialysis against distilled water for 48 h, and was freeze dried.
Analysis of Conjugates by RP-HPLC
The compositions of the conjugates were analysed by RP-HPLC with a Delta-Pak RP C 18 column (7.8 mm × 30 cm) packed with spherical 15-µm silica of 300 Å pore size (Nixon Waters Ltd., Tokyo, Japan). We used an eluent system of 0.1% TFA in water (eluent A) and 0.1% TFA in acetonitrile/water = 80/ 20 v/v (eluent B) using high-purity (Analar) solvents and distilled, deionized water. The elution gradient was 10-100% eluent B in 35 min. The injection volume was 100 µL containing 10 µg of conjugate, polymer, or peptide. Compounds were dissolved in eluent immediately before application and filtered through 0.45-µm Spartan 13 (Schleicher and Schuell, Dassel, Germany) filters. Free peptide or polymer polypeptide samples were run as standards and their retention times were determined. UV absorbance was monitored at a wavelength of 220 nm. All analyses were carried out at ambient temperature with a flow rate of 1.0 mL/min. As a control, in some cases, the HPLC profile of the peptide and conjugate mixture was also recorded.
Three-Component Conjugate Containing Multiple Copies of Two Uniformly Oriented Antibody Peptide Epitopes
We have described a novel approach in which the carrier polypeptide is modified by 3-nitro-2-pyridinesulfenyl (Npys)-protected Cys (24); this derivative has been used for the conjugation of Cys-containing epitope peptides to poly [Lys]-based branched polypeptides (25) . Considering the stability of the Npys group in the presence of pentafluorophenol, the Boc-Cys(Npys)-OPfp derivative was selected for the introduction of Npys groups to the N-terminal of the branches of polypeptide backbones. This new class of Cys(Npys)-derivatized branched polypeptides is stable for a couple of months and suitable for the effective preparation of epitope-peptide conjugates possessing increased water solubility. The incorporation of epitope peptides depends on the number of Npys groups in polymers as well as on the presence/absence of Boc-protecting group on the Cys residue. A conjugate was prepared in which two epitopes ( 9 LKNleA DPNRFRGKDL 22 and 276 SALLEDPVG 284 ) (21,26) of HSV gD type 1 joined by a dipeptide Acp-Cys spacer (where Acp is e-amino caproic acid) were attached through the SH function of a single peptide to the Cys(Npys) modified branched polypeptide (Fig. 6) . 20 mg (57 µmol) poly[Lys(DL-Ala 3.11 )] (AK, DP n = 66, MW monomer = 349) dissolved in 0.5 mL deionized water was diluted with 3 mL DMF. An equivalent amount of Boc-Cys(Npys)-OPfp (31 mg) dissolved in 2 mL DMF was added to the solution (see Notes 3 and 4). The reaction mixture was stirred overnight at RT. The solvent was removed in vacuo (30°C) and the remaining product was washed with ether (containing 10% DCM) repeatedly to remove unreacted ester and pentafluorophenol. Yield: 35 mg (see Note 5) . The Boc-group was removed by 5 mL TFA-water (95:5, v/v) at 0°C for 1 h in the presence of 5% pcresol. The solution was concentrated in vacuo, then dissolved in water and dialyzed against 0.1% acetic acid solution for 2 d and freeze dried (yield: 27 mg). The average degree of substitution was calculated from the UV absorption of the Npys group at l = 350 nm (e = 3930/M/cm in DMF) (27).
Synthesis of Branched Polypeptides With Cys(Npys)Residues

Conjugation of Epitope Peptides to Branched Polypeptides With Cys(Npys) Residues
Boc-deprotected branched polypeptide with the Cys(Npys) moiety, poly [Lys(Cys 0.27 -DL-Ala 3.1 )] trifluoroacetate salt (10 mg, 16.5 µmol), was dissolved in 10 mL 0.06 M phosphate buffer (pH 5.5) (see Note 6) 1.35 amount of HLKNleADPNRFRGKDL-Acp-CSALLEDPVG-NH 2 (14.8 mg, 5.4 µmol), calculated from the Npys-content of polymer, was added to the reaction mixture. The final concentration was 1 mg/mL for the polymer component. The solution was stirred for 4 h at RT, transferred to a Visking tube (cutoff 8000-12,000), and dialyzed for 2 d against 0.1% acetic acid. No Npys content was detected by UV spectroscopy at l = 350 nm in the conjugate after freeze drying (see Note 7). 
